Next Article in Journal
Oncology Clinicians’ Challenges to Providing Palliative Cancer Care—A Theoretical Domains Framework, Pan-Cancer System Survey
Next Article in Special Issue
Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients
Previous Article in Journal
A Comparison of Patient-Reported Outcomes Following Consent for Genetic Testing Using an Oncologist- or Genetic Counselor-Mediated Model of Care
 
 
Article

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer

1
School of Nursing, University of British Columbia, Vancouver, BC V6T 2B5, Canada
2
BC Cancer, Vancouver, BC V5Z 4E6, Canada
3
College of Nursing, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada
4
School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2021, 28(2), 1472-1482; https://doi.org/10.3390/curroncol28020139
Received: 20 February 2021 / Accepted: 29 March 2021 / Published: 9 April 2021
(This article belongs to the Special Issue Translational Research in Breast Cancer Patients)
Adherence to adjuvant endocrine therapy (AET) for breast cancer is suboptimal. The purpose of this study was to: (1) explore the experiences and perspectives of healthcare providers (HCPs) in providing care to breast cancer survivors prescribed AET, (2) identify how social and structural factors influence the provision of AET-related care, and (3) ascertain HCP recommendations for optimizing AET adherence and related care. Individual, in-depth interviews were conducted with 14 HCPs using an interpretive descriptive approach to inquiry and the theoretical lens of relational autonomy. Data was analyzed using thematic and constant comparative techniques. Healthcare providers focused on four main components of AET-related care: (1) the importance of having careful conversations about AET, (2) difficulties in navigating transitions in care, (3) symptom management as a big part of their role, and (4) dealing with AET discontinuation. Recommendations to improve AET adherence focused on developing sustainable and efficient models of delivering high-quality care to women on AET. Healthcare providers play a pivotal role educating women about AET and supporting their adherence to therapy. Sustainable healthcare system innovations and new models of care that address current system gaps are needed to enhance survivorship care, AET adherence, and ultimately, reduce cancer recurrence and mortality. View Full-Text
Keywords: adjuvant endocrine therapy; medication adherence; breast cancer; cancer survivorship adjuvant endocrine therapy; medication adherence; breast cancer; cancer survivorship
MDPI and ACS Style

Lambert, L.K.; Balneaves, L.G.; Howard, A.F.; Chia, S.L.K.; Gotay, C.C. Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer. Curr. Oncol. 2021, 28, 1472-1482. https://doi.org/10.3390/curroncol28020139

AMA Style

Lambert LK, Balneaves LG, Howard AF, Chia SLK, Gotay CC. Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer. Current Oncology. 2021; 28(2):1472-1482. https://doi.org/10.3390/curroncol28020139

Chicago/Turabian Style

Lambert, Leah K., Lynda G. Balneaves, A. Fuchsia Howard, Stephen L. K. Chia, and Carolyn C. Gotay. 2021. "Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer" Current Oncology 28, no. 2: 1472-1482. https://doi.org/10.3390/curroncol28020139

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop